Table 1 (abstract P116). TNF inhibitor treatment
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Uveitis Group | Infliximab N=7 (Remission) | Adalimumab N= 6 (Remission) |
|---|---|---|
Idiopathic | 4 (3) | 5 (3) |
JIA-U | 3 (1) | 1 (1) |
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Uveitis Group | Infliximab N=7 (Remission) | Adalimumab N= 6 (Remission) |
|---|---|---|
Idiopathic | 4 (3) | 5 (3) |
JIA-U | 3 (1) | 1 (1) |
Pediatric Rheumatology